MTOR and neoplasm: Hyperactivation of mechanistic target of rapamycin (mTOR), often due to mutations in upstream regulators [e.g., the tumor suppressor tuberous sclerosis complex (TSC1/2)], promotes anabolic processes and tumor growth [115].